报价延迟最少15分钟:2026/03/12 12:59 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.12 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.86/--
|
|
企业价值
183.97M
|
| 资产负债 |
|
每股账面净值
7.06
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
348.67M
|
|
每股收益
12.83
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products. |
